National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 7/16/2021 release of VAERS data:

Found 11,519 cases where Vaccine is COVID19 and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis



Case Details

This is page 11 out of 1,152

Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next


VAERS ID: 946900 (history)  
Form: Version 2.0  
Age: 43.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2020-12-18
Onset:2021-01-03
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-01-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0140 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Angioplasty, Computerised tomogram abdomen abnormal, Computerised tomogram pelvis abnormal, Deep vein thrombosis, Iliac vein occlusion, May-Thurner syndrome, Pain in extremity, Pelvic venous thrombosis, Peripheral artery stent insertion, Peripheral swelling, Scan with contrast abnormal, Thrombectomy, Thrombolysis, Ultrasound Doppler abnormal, Venogram
SMQs:, Cardiac failure (broad), Angioedema (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Thrombophlebitis (narrow), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Medication List As of 12/18/2020 ?9:22 AM Amoxicillin-Pot Clavulanate 875-125 mg 1 tablet Oral Every 12 hours scheduled Ergocalciferol 50,000 Units Oral Weekly Patient not taking: Reported on 7/23/2020 Liraglutide -Weight Management 3
Current Illness: increasing sinus pressure postnasal drainage sore throat 99 temp congestion
Preexisting Conditions: Problem List As of 12/18/2020 ?9:10 AM Class II obesity Dysmetabolic syndrome X Facial rhytids Family history of uterine cancer Lipoprotein deficiency Low serum HDL Vitamin D insufficiency Prediabetes
Allergies: nka
Diagnostic Lab Data: 1/4/21 CT ABDOMEN AND PELVIS WITH IV CONTRAST VESSELS: There is enlargement and complete thrombosis of the left common, internal and external iliac veins, with adjacent fat stranding noted. There is thrombus in the visualized left femoral vein. No thrombus appreciated in the right-sided iliac veins or inferior vena cava. Normal abdominal aorta. IMPRESSION: Extensive occlusive thrombus in the left common, internal and external iliac veins. VAS lower limb venous duplex study, complete bilateral RIGHT LOWER LIMB: No gross evidence of acute or chronic deep vein thrombosis. No evidence of superficial thrombophlebitis noted. Doppler evaluation shows a normal response to augmentation maneuvers. Popliteal, posterior tibial and anterior tibial arterial Doppler waveforms are triphasic. LEFT LOWER LIMB: Slow flow versus acute deep vein thrombosis is noted in the common femoral vein, saphenofemoral junction, and proximal femoral vein. No evidence of superficial thrombophlebitis noted. Doppler evaluation shows a normal response to augmentation maneuvers. Popliteal, posterior tibial and anterior tibial arterial Doppler waveforms are triphasic/biphasic. 1/5/21 LEFT LOWER EXTREMITY AND PELVIC VENOGRAM. MECHANICAL THROMBECTOMY, ANGIOPLASTY, AND STENT IMPRESSION: Impression: Successful mechanical thrombectomy of the iliofemoral thrombus demonstrating a May Thurner syndrome treated with a 16 mm stent and angioplasty
CDC Split Type:

Write-up: Hospital Course: ? Patient is a 43 y.o. female patient who originally presented to the hospital on 1/3/2021 due to Left lower extremity pain and swelling. Patient found to have extensive DVT of left lower extremity and started on heparin drip. Vascular was consulted and recommended thrombolysis. Patient was also seen by IR who took patient for thrombectomy and left iliac stent placement on 01/05/2021. Patient tolerated procedure well. Patient was transitioned from heparin drip to Eliquis upon discharge. Patient given vascular follow-up as well as Hematology follow-up.


VAERS ID: 946978 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Male  
Location: Florida  
Vaccinated:2020-12-29
Onset:2021-01-03
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-01-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA LOT#026L20A / 2 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Anticoagulant therapy, Asthenia, Chest X-ray normal, Computerised tomogram thorax abnormal, Cough, Deep vein thrombosis, Dyspnoea, Dyspnoea exertional, Fatigue, Fibrin D dimer increased, Heart rate increased, Intensive care, Oxygen saturation decreased, Pneumonia, Pulmonary embolism, Respiratory distress, SARS-CoV-2 test negative, Thrombolysis, Ultrasound Doppler abnormal
SMQs:, Anaphylactic reaction (broad), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Dehydration (broad), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: lexothyroxine, vitamin D, montelukast, manesium citrate
Current Illness: Sinus infection at the beginning of December treated with augmentin
Preexisting Conditions: hypothyroidism, allergic rhinitis
Allergies: NKDA
Diagnostic Lab Data: PCR covid test 1/4/21 negative Chest Xray 1/6/21 negative at the ER at the Medical Center on 1/10/21 d-dimer levels were very high, chest CT showed multiple bilateral pulmonary emboli, leg US revealed bilateral emboli
CDC Split Type:

Write-up: Onset of shortness of breath and cough on 1/3 that progressively got worse. Clinical diagnosis of pneumonia without fever was made, patient started azithromycin on 1/5 and albuterol treatments every 4-6 hrs. Initially he improved, but then worsened. chest xray on 1/6 was negative for pneumonia, PCR covid test was negative, albuterol treatment did not bring much relief. He started respiratory distress on 1/10 and was taken by car to the local ER where another covid test was negative and chest CT revealed multiple bilateral pulmonary emboli. The leg US revealed blood clots in both of his legs. He had an emergency catheter-delivered thrombolysis and was discharged home from the ICU on 1/12 on oral anticoagulants. He is gradually improving, but very weak. He tires easily and gets a drop in oxygen to 90- 93%, as well as an increase in the heart rate to 120 when walking less than half a mile. He runs out of breath with exertion.


VAERS ID: 947139 (history)  
Form: Version 2.0  
Age: 41.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-01-09
Onset:2021-01-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3246 / 2 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Arthralgia, Chills, Fatigue, Hyperhidrosis, Inflammation, Injection site pain, Injection site swelling, Malaise, Oedema peripheral, Petechiae, Swelling, Urticaria
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Day of vaccine, patient started feeling fatigue, malaise, site pain & swelling, joint pain all over, profuse sweating w/no fever, chills, all over inflammation & swelling, hives upper extremity, petechial rash, and the next day after the vaccine, the patient started experiencing swelling in R-axilla (lemon size). 3 days after vaccine all symptoms have resolved except swelling in right axilla.


VAERS ID: 947392 (history)  
Form: Version 2.0  
Age: 63.0  
Sex: Female  
Location: Ohio  
Vaccinated:2021-01-13
Onset:2021-01-13
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-01-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 039K20A / 1 LA / SYR

Administered by: Work       Purchased by: ?
Symptoms: Injection site bruising, Pain in extremity, Purpura
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: Chronic Venous Insufficiency
Allergies: None
Diagnostic Lab Data: None
CDC Split Type:

Write-up: Unusual pattern of bruising at injection site - bruising with 3 reddish/purplish small round circles underneath the skin. Circles are all approximately the same size, and all are on the same horizontal "line". Bruising started appearing evening of the injection. Left arm was very sore, especially the evening of the injection. Bruising and circles still visible two days later, but pain is negligible.


VAERS ID: 947816 (history)  
Form: Version 2.0  
Age: 56.0  
Sex: Female  
Location: Virginia  
Vaccinated:2021-01-12
Onset:2021-01-14
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-01-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Military       Purchased by: ?
Symptoms: Blood creatine phosphokinase increased, Lymphopenia, Platelet count decreased, Rhabdomyolysis, Thrombocytopenia, White blood cell count decreased
SMQs:, Rhabdomyolysis/myopathy (narrow), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (narrow), Myocardial infarction (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: synthroid, mutli-vitamin, Vit C, whey protein
Current Illness:
Preexisting Conditions: hypothyroidism, seasonal allergies
Allergies: Mango, nickel
Diagnostic Lab Data: as above 1/14 WBC 2.7 and plt 145 CK 3400
CDC Split Type:

Write-up: mild rhabdomyolysis presentation and lymphopenia and thrombocytopenia


VAERS ID: 948082 (history)  
Form: Version 2.0  
Age: 39.0  
Sex: Female  
Location: Kansas  
Vaccinated:2021-01-04
Onset:2021-01-06
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-01-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Catheterisation cardiac, Myocardial infarction, Stent placement
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: COVID (+) 14 days prior with quarantine ending on 1/1/21
Preexisting Conditions: Cardiogenic shock in 2003 related to substance usage
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient had just recovered from COVID and ended quarantine on 1/1/21. On 1/4/21, she received the first COVID vaccination. While driving home on 1/6/21, she experienced an MI diagnosed in the emergency room 30 minutes later. She was admitted to the hospital and underwent a heart catheterization and received a STENT. She had previous cardiogenic shock in 2003.


VAERS ID: 949555 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Male  
Location: New York  
Vaccinated:2021-01-13
Onset:2021-01-14
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0142 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Ataxia, Cerebral infarction, Computerised tomogram head abnormal, Computerised tomogram neck, Gait disturbance, Ischaemic stroke, Magnetic resonance imaging brain abnormal, Scan with contrast abnormal, Thrombosis
SMQs:, Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Parkinson-like events (broad), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Baby Aspirin, Advil PM , vitamin D, atorvastatin 20 mg
Current Illness: No
Preexisting Conditions: hyperlipidemia. Overweigh, osteoarthritis
Allergies: NO
Diagnostic Lab Data: Ct scan of head and neck with contrast demonstrated small clots in right vertebral artery. MRI of brain demonstrated an acute ischemic stroke in the right PCA territory.
CDC Split Type:

Write-up: Received Pfizer vaccine, first dose on Wed. 01/13/21 between 12 and 1 P.M. Thurs. 01/14/21 in the afternoon he began to note that he had difficultly walking. Went to bed when he woke up at 5:48 A.M. he reported he had ataxia. Patient reported having to walk in tiny steps to stay upright. He went to the emergency room. Had CT scan of head and found blood clots. MRI performed. Stroke found in right PCA territory, but no loss in strength in left lower extremity. Sensation and vision intact. Strength in all four extremities is 5 out of 5.


VAERS ID: 949641 (history)  
Form: Version 2.0  
Age: 52.0  
Sex: Female  
Location: South Carolina  
Vaccinated:2021-01-05
Onset:2021-01-10
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-01-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK9231 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Activated partial thromboplastin time normal, Full blood count abnormal, Metabolic function test, Petechiae, Rash, Skin lesion
SMQs:, Anaphylactic reaction (broad), Haematopoietic leukopenia (broad), Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Rosuvastatin - 10 mg po Q Day
Current Illness: None
Preexisting Conditions: None
Allergies: Sulfa drugs
Diagnostic Lab Data: CBC with differential; CMP; and PT/PTT - all normal - 01/14/2021 Rash is still visible on palms of hands but is resolving as of 01/15/2021.
CDC Split Type:

Write-up: A petechial rash developed on my bilateral palms of hands, left greater than right, on 01/10/2021. There was no rash noted on my feet or body habitus. When the lesions became darker and more punctate , decision was made to seek medical attention. There was no history of trauma, fever, or skin injury. I saw my Internist, on 01/14/2021 for evaluation and treatment.


VAERS ID: 949679 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-01-09
Onset:2021-01-14
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-01-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Blood creatine phosphokinase, Full blood count, Influenza like illness, Metabolic function test, Thrombocytopenia
SMQs:, Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: CBC, CMP, CPK
CDC Split Type:

Write-up: COVID 19 vaccine - unsure which vaccination Flu like symptoms for 1 day with noted thrombocytopenia 127 x 10^3 Unclear if thrombocytopenia is from vaccination. No hx of this


VAERS ID: 949920 (history)  
Form: Version 2.0  
Age: 73.0  
Sex: Male  
Location: New Hampshire  
Vaccinated:2021-01-01
Onset:2021-01-14
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-01-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / SYR

Administered by: Other       Purchased by: ?
Symptoms: Angiogram, Chest discomfort, Chest pain, Myocardial infarction
SMQs:, Anaphylactic reaction (broad), Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Irbesarten 300mg Symbicort 160 Celebrex 200
Current Illness: None
Preexisting Conditions: COPD
Allergies: None
Diagnostic Lab Data: 1/14/2021 angiogram slight blockage no stent required
CDC Split Type:

Write-up: Tightness and pain in chest leading to hospitalization and diagnosis of heart attack at 3 am


Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=11&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166